Targeting TRIB3 and PML-RARα interaction against APL

Oncotarget. 2017 Jul 22;8(32):52012-52013. doi: 10.18632/oncotarget.19442. eCollection 2017 Aug 8.

Authors

Ke Li¹, Feng Wang¹, Zhuo-Wei Hu¹

Affiliation

¹ Immunology and Cancer Pharmacology Group, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

No abstract available

Keywords: AML; protein quality control; protein-protein interactions; sumoylation; α-helical peptide.

Publication types

Editorial